Tolmar Announces Acquisition of JATENZO (testosterone undecanoate) for the Treatment of Hypogonadism to Expand its Market Leading Urology Portfolio


Hitesh

Tolmar Announces Acquisition of JATENZO : Launched in 2020, JATENZO was the first oral softgel testosterone medicine approved in the US by the FDA in more than 60 years JATENZO is an oral softgel testosterone undecanoate for testosterone replacement therapy in adult males for conditions associated with a deficiency or […]

MedAlliance is acquired by Cordis


Hitesh

MedAlliance is acquired by Cordis : MedAlliance, a Swiss-based provider of medical technology, recently announced that it had reached a deal with Cordis for an initial investment of US$35 million, a $200 million upfront payment at closing, up to $125 million in regulatory milestone payments, up to $775 million in […]

Allergy Partners Announces Collaboration with Aimmune Therapeutics to Provide PALFORZIA Directly to Patients


Hitesh

PALFORZIA : Peanut (Arachis hypogaea) Allergen Powder-dnfp Aimmune Therapeutics, Inc., a Nestlé Health Science company developing pharmaceutical therapies to prevent, manage, and treat food, gastrointestinal, and metabolic-related diseases, and Allergy Partners, the nation’s largest single specialty allergy practise group, have announced a strategic partnership to provide Allergy Partners’ patients aged […]

The acquisition of Devicia and Clarvin by Veranex will increase its regulatory, qualitative, and clinical expertise in IVD and medical devices.


Hitesh

medical devices and IVD clinical expertise will increase because of the acquisition of Devicia and Clarvin by Veranex Veranex, the only comprehensive, international, technology-enabled service provider to the medical device industry, announced today that it has acquired a network of full-service medical device consulting companies that cover clinical and regulatory […]